Effects of Spirulina supplementation on obese patients

Phase 2

• Conditions: obesity.; Obesity, Localized adiposity; E-66, E-65

• Registration Number: IRCT2016101615968N4
• Lead Sponsor: Vice chancellor for research, Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

aged 20-60 years old, 40 kg/m2 >BMI>25 kg/m2, no history of medications for obesity, diabetes, dyslipidemia, inflammatory diseases and vitamin supplementation within 3 months before the study
Exclusion criteria: having chronic kidney or hepatic disease except NAFLD, hypo or hyperthyroidism, autoimmune and infectious disease, weight reduction diet therapy within 6 month, more than 3 kg weight change in recent 2 months and recent surgery, taking anticoagulant medications the same as warfarin or aspirin, pregnancy and lactation

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified